A conservative group is alleging that President Biden’s nominee to helm the National Institute of Health has “problematic close ties with big pharma.”

It found that her associated research garnered more than $350 million in funding from pharmaceutical companies and that she opposed a key Trump administration policy meant to rein in drug prices.

Dr. Bertagnolli’s extensive financial ties to pharmaceutical companies raise serious questions about her ability to lead NIH in a manner that is not beholden to special or secret interests.”

“Big Pharma bankrolled her career, and she has long been a friend and ally to them. Especially after the corruption and lies that came from the government’s medical agencies during COVID, the American people need to know that NIH will be led by honest people who serve them, and are not owned by massive corporations,”